4FSF

Crystal structure of Pseudomonas aeruginosa PBP3 complexed with compound 14


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.20 Å
  • R-Value Free: 0.275 
  • R-Value Work: 0.216 
  • R-Value Observed: 0.220 

wwPDB Validation   3D Report Full Report


Ligand Structure Quality Assessment 


This is version 1.0 of the entry. See complete history


Literature

Novel monobactams utilizing a siderophore uptake mechanism for the treatment of gram-negative infections.

Mitton-Fry, M.J.Arcari, J.T.Brown, M.F.Casavant, J.M.Finegan, S.M.Flanagan, M.E.Gao, H.George, D.M.Gerstenberger, B.S.Han, S.Hardink, J.R.Harris, T.M.Hoang, T.Huband, M.D.Irvine, R.Lall, M.S.Megan Lemmon, M.Li, C.Lin, J.McCurdy, S.P.Mueller, J.P.Mullins, L.Niosi, M.Noe, M.C.Pattavina, D.Penzien, J.Plummer, M.S.Risley, H.Schuff, B.P.Shanmugasundaram, V.Starr, J.T.Sun, J.Winton, J.Young, J.A.

(2012) Bioorg Med Chem Lett 22: 5989-5994

  • DOI: https://doi.org/10.1016/j.bmcl.2012.07.005
  • Primary Citation of Related Structures:  
    4FSF

  • PubMed Abstract: 

    Novel siderophore-linked monobactams with in vitro and in vivo anti-microbial activity against MDR Gram-negative pathogens are described.


  • Organizational Affiliation

    Medicinal Chemistry, Pfizer Worldwide Research and Development, Eastern Point Road, Groton, CT 06340, USA.


Macromolecules
Find similar proteins by:  (by identity cutoff)  |  3D Structure
Entity ID: 1
MoleculeChains Sequence LengthOrganismDetailsImage
Penicillin-binding protein 3536Pseudomonas aeruginosaMutation(s): 0 
Gene Names: ftsI
UniProt
Find proteins for Q51504 (Pseudomonas aeruginosa)
Explore Q51504 
Go to UniProtKB:  Q51504
Entity Groups  
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupQ51504
Sequence Annotations
Expand
  • Reference Sequence
Small Molecules
Ligands 1 Unique
IDChains Name / Formula / InChI Key2D Diagram3D Interactions
0W0
Query on 0W0

Download Ideal Coordinates CCD File 
B [auth A](4R,5S,8Z)-8-(2-amino-1,3-thiazol-4-yl)-1-[3-(1,5-dihydroxy-4-oxo-1,4-dihydropyridin-2-yl)-1,2-oxazol-5-yl]-5-formyl-11,11-dimethyl-1,7-dioxo-4-(sulfoamino)-10-oxa-2,6,9-triazadodec-8-en-12-oic acid
C22 H24 N8 O13 S2
OFOVQVNKWTUULV-NEEHKMPWSA-N
Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.20 Å
  • R-Value Free: 0.275 
  • R-Value Work: 0.216 
  • R-Value Observed: 0.220 
  • Space Group: P 21 21 21
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 67.64α = 90
b = 82.723β = 90
c = 88.747γ = 90
Software Package:
Software NamePurpose
HKL-2000data collection
PHASERphasing
BUSTERrefinement
HKL-3000data reduction
SCALEPACKdata scaling

Structure Validation

View Full Validation Report



Ligand Structure Quality Assessment 


Entry History 

Deposition Data

  • Released Date: 2012-10-17 
  • Deposition Author(s): Han, S.

Revision History  (Full details and data files)

  • Version 1.0: 2012-10-17
    Type: Initial release